
0.7431 Delayed Data As of Nov 30 | ![]() Today’s Change | 0.50 Today|||52-Week Range 1.39 | +40.61% Year-to-Date |
The 2 analysts offering 12-month price forecasts for Atossa Therapeutics Inc have a median target of 4.75, with a high estimate of 5.50 and a low estimate of 4.00. The median estimate represents a +539.21% increase from the last price of 0.74.
The current consensus among 3 polled investment analysts is to Buy stock in Atossa Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.